ReP USP - Resultado da busca

Filtros : "ALMEIDA, BIANCA DA SILVA" "PARASITOLOGIA" "CARVALHO, ALEXIA ADRIANNE VENCESLAU BRITO" Limpar

Filtros

Autores USP
- almeida, bianca da silva (2)
- amarante, maria fernanda de castro (2)
- boscardin, silvia beatriz (2)
- carvalho, alexia adrianne venceslau brito (2)
- ferreira, luis carlos de souza (2)

Artigo de periodico
Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein (2024)
Silva, Mariângela de Oliveira ; Castro-Amarante, Maria Fernanda ; Carvalho, Alexia Adrianne Venceslau Brito ; Almeida, Bianca da Silva; Daher, Isabela Pazotti ; Souza-Silva, Guilherme Antonio de ; Yamamoto, Marcio Massao ; Koike, Gabriela ; Souza, Edmarcia Elisa de ; Wrenger, Carsten ; Ferreira, Luis Carlos de Souza ; Boscardin, Silvia Beatriz
Fonte: Vaccines. Unidades: ICB, FM
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, PROTEÍNAS RECOMBINANTES, PROTEÍNAS SANGUÍNEAS, ANTICORPOS, IMUNOGENICIDADE DA VACINA, IMUNOGENÉTICA, IMUNOGLOBULINAS, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12040356. Acesso em: 07 ago. 2024.
APA
Silva, M. de O., Castro-Amarante, M. F., Carvalho, A. A. V. B., Almeida, B. da S., Daher, I. P., Souza-Silva, G. A. de, et al. (2024). Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, 12( 4), 14 . doi:10.3390/vaccines12040356
NLM
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 ago. 07 ] Available from: https://doi.org/10.3390/vaccines12040356
Vancouver
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 ago. 07 ] Available from: https://doi.org/10.3390/vaccines12040356
Artigo de periodico
Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation (2022)
Jesus, Monica Josiane Rodrigues de ; Favaro, Marianna Teixeira de Pinho ; Carvalho, Aléxia Adrianne Venceslau Brito ; Amarante, Maria Fernanda de Castro ; Almeida, Bianca da Silva ; Silva, Mariângela de Oliveira ; Santos, Robert Andreata ; Barbosa, Cecilia Gomes; Brito, Samantha Carvalho Maia; Freitas Junior, Lucio Holanda Gondim de ; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Fonte: Nanomedicine: Nanotechnology, Biology and Medicine. Unidades: BIOTECNOLOGIA, ICB
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, VACINAS VIRAIS, IMUNOGLOBULINAS, CORONAVIRUS, COVID-19, LIPOPROTEÍNAS, NANOPARTÍCULAS, CAMUNDONGOS, IMUNOGENICIDADE DA VACINA, DOENÇAS RESPIRATÓRIAS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, Monica Josiane Rodrigues de et al. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, v. 45, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2022.102595. Acesso em: 07 ago. 2024.
APA
Jesus, M. J. R. de, Favaro, M. T. de P., Carvalho, A. A. V. B., Amarante, M. F. de C., Almeida, B. da S., Silva, M. de O., et al. (2022). Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, 45, 1-11. doi:10.1016/j.nano.2022.102595
NLM
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1016/j.nano.2022.102595
Vancouver
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1016/j.nano.2022.102595

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo 2012 - 2024